AI adoption by physicians has surged to over 80%, yet many express balanced views, excited by potential but concerned about ...

In a Rwanda-based evaluation, LLM judges produced consistent and far cheaper ratings of clinical AI responses but matched ...

OpenEvidence and Doximity are touting dueling NOHARM benchmark wins, the latest round in a wave of clinical AI safety studies with conflicting results.

The study failure costs Agios a chance to one-up Novo Nordisk and represents yet another setback in a disease that’s ...

On July 14, the U.S. Food and Drug Administration (FDA) announced it is seeking public input regarding the patient safety impacts of certain ...

Making clinical decision-making is often a team effort. Patients seeking cancer treatment, for instance, may have a surgeon, ...

Abstract: Explainable artificial intelligence is critical for trust in clinical decision making. In health care, where the stakes are high, poor data can lead to misleading insights and de-skilling.

Abstract: AI-based Clinical Decision Support Systems are a revolutionary innovation in the healthcare sector, using artificial intelligence to improve diagnostic precision, optimize treatment planning ...

YOU ARE HERE: Home > Guidelines and Clinical Policy > 2024 ACC Expert Consensus Decision Pathway on Clinical Assessment, Management, and Trajectory of Patients Hospitalized With Heart Failure Focused ...